//
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure